The Search for a Better Treatment for RecurrentClostridium difficileDisease: Use of High‐Dose Vancomycin Combined withSaccharomyces boulardii
Top Cited Papers
Open Access
- 1 October 2000
- journal article
- clinical trial
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 31 (4), 1012-1017
- https://doi.org/10.1086/318130
Abstract
Recurrent Clostridium difficile disease (CDD) is a difficult clinical problem because antibiotic therapy often does not prevent further recurrences.Keywords
This publication has 27 references indexed in Scilit:
- Biotherapeutic Agents and Infectious DiseasesPublished by Springer Nature ,1999
- Recurrent Clostridium difficile Diarrhea: Characteristics of and Risk Factors for Patients Enrolled in a Prospective, Randomized, Double-Blinded TrialClinical Infectious Diseases, 1997
- Biotherapeutic agents. A neglected modality for the treatment and prevention of selected intestinal and vaginal infectionsJAMA, 1996
- Clostridium difficile-Associated Diarrhea and ColitisInfection Control & Hospital Epidemiology, 1995
- A randomized placebo-controlled trial of Saccharomyces boulardii in combination with standard antibiotics for Clostridium difficile diseaseJAMA, 1994
- Ten Years of Prospective Clostridium difficile-Associated Disease Surveillance and Treatment at the Minneapolis VA Medical Center, 1982-1991Infection Control & Hospital Epidemiology, 1994
- Epidemiology of Community-Acquired Clostridium difficile-Associated DiarrheaThe Journal of Infectious Diseases, 1994
- Saccharomyces boulardii for Clostridium difficile-Associated Enteropathies in InfantsJournal of Pediatric Gastroenterology and Nutrition, 1993
- Saccharomyces boulardii'. A Review of an Innovative Biotherapeutic AgentMicrobial Ecology in Health & Disease, 1993
- Prevention of antibiotic-associated diarrhea by Saccharomyces boulardii: A prospective studyGastroenterology, 1989